Calamos Advisors’s Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CNDA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-92,316
Closed -$10.6K 1013
2024
Q2
$10.6K Hold
92,316
﹤0.01% 886
2024
Q1
$10.3K Hold
92,316
﹤0.01% 894
2023
Q4
$12K Hold
92,316
﹤0.01% 839
2023
Q3
$7.57K Hold
92,316
﹤0.01% 885
2023
Q2
$3.69K Hold
92,316
﹤0.01% 974
2023
Q1
$6.85K Hold
92,316
﹤0.01% 1081
2022
Q4
$10K Hold
92,316
﹤0.01% 1103
2022
Q3
$17K Buy
+92,316
New +$21.6K ﹤0.01% 1133

Other funds holding CNDA.WS

Calamos Advisors's CNDA.WS Position: Q3 2024 in Review

Calamos Advisors sold out of Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CNDA.WS) in Q3 2024, closing a stake of 92,316 shares — an estimated $10.6K sold.

Calamos Advisors first reported a position in CNDA.WS in Q3 2022 and held it in 8 quarters. The position peaked at $17K in Q3 2022. 5 funds tracked by Wall St. Rank hold CNDA.WS as of Q3 2024.

  • Calamos Advisors reported no remaining Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • Calamos Advisors sold 92,316 Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q3 2024, an estimated $10.6K.
  • Calamos Advisors first reported a position in Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q3 2022 and held it in 8 quarters.
  • Calamos Advisors's Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $17K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q3 2024.

Based on Calamos Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.